JPS516109B2 - - Google Patents

Info

Publication number
JPS516109B2
JPS516109B2 JP144973A JP144973A JPS516109B2 JP S516109 B2 JPS516109 B2 JP S516109B2 JP 144973 A JP144973 A JP 144973A JP 144973 A JP144973 A JP 144973A JP S516109 B2 JPS516109 B2 JP S516109B2
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP144973A
Other languages
Japanese (ja)
Other versions
JPS4990296A (https=
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP144973A priority Critical patent/JPS516109B2/ja
Publication of JPS4990296A publication Critical patent/JPS4990296A/ja
Publication of JPS516109B2 publication Critical patent/JPS516109B2/ja
Expired legal-status Critical Current

Links

Landscapes

  • Oxygen, Ozone, And Oxides In General (AREA)
JP144973A 1972-12-28 1972-12-28 Expired JPS516109B2 (https=)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP144973A JPS516109B2 (https=) 1972-12-28 1972-12-28

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP144973A JPS516109B2 (https=) 1972-12-28 1972-12-28

Publications (2)

Publication Number Publication Date
JPS4990296A JPS4990296A (https=) 1974-08-28
JPS516109B2 true JPS516109B2 (https=) 1976-02-25

Family

ID=11501737

Family Applications (1)

Application Number Title Priority Date Filing Date
JP144973A Expired JPS516109B2 (https=) 1972-12-28 1972-12-28

Country Status (1)

Country Link
JP (1) JPS516109B2 (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10751353B2 (en) 2013-05-07 2020-08-25 Seelos Therapeutics, Inc. Compositions and methods for treating an aggregation disease or disorder
US10869831B2 (en) 2013-05-07 2020-12-22 Seelos Therapeutics, Inc. Treatment of protein aggregation myopathic and neurodegenerative diseases by parenteral administration of trehalose

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52119495A (en) * 1976-03-31 1977-10-06 Sumitomo Precision Prod Co Apparatus for controlling ozone generating volume

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10751353B2 (en) 2013-05-07 2020-08-25 Seelos Therapeutics, Inc. Compositions and methods for treating an aggregation disease or disorder
US10869831B2 (en) 2013-05-07 2020-12-22 Seelos Therapeutics, Inc. Treatment of protein aggregation myopathic and neurodegenerative diseases by parenteral administration of trehalose

Also Published As

Publication number Publication date
JPS4990296A (https=) 1974-08-28

Similar Documents

Publication Publication Date Title
CS161815B2 (https=)
CS171185B2 (https=)
CS166174B2 (https=)
JPS516109B2 (https=)
JPS4939893U (https=)
CS162150B1 (https=)
CS162227B1 (https=)
CS162173B1 (https=)
CS166330B1 (https=)
CS166336B1 (https=)
CS160574B1 (https=)
CS159926B1 (https=)
CS159583B1 (https=)
CS158495B1 (https=)
CS158015B1 (https=)
CS153946B1 (https=)
CS153172B1 (https=)
CH568774A5 (https=)
CH606255A5 (https=)
CH584677A5 (https=)
CH585027A5 (https=)
CH587250A5 (https=)
CH587253A5 (https=)
CH590233A5 (https=)
CH590243A5 (https=)